Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Prostate|April 21, 2015
Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention TrialChristopher M Heaphy, Gaurav Gaonkar, Sarah B Peskoe, et al.
The Prostate|November 23, 2017
Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cellsCorinne E Joshu, Sarah B Peskoe, Christopher M Heaphy, et al.
Kidney Medicine|September 12, 2022
Decisional Conflict About Kidney Failure Treatment Modalities Among Adults With Advanced CKDNicole DePasquale, Jamie A Green, Patti L Ephraim, et al.
Clinical Transplantation|January 10, 2021
African Americans' discussions about living-donor kidney transplants with family or friends: Who, what, and why not?Nicole DePasquale, Matthew J Ellis, Debra L Sudan, et al.
Cancer Discovery|June 20, 2013
Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and deathChristopher M Heaphy, Ghil Suk Yoon, Sarah B Peskoe, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
A Lasting Legacy: Long-Term Effects of Exercise Training on Cardiometabolic Health in the STRRIDE-Prediabetes Reunion StudyLeanna M Ross, Alyssa M Sudnick, Katherine A Collins-Bennett, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 21, 2015
Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal CellsCorinne E Joshu, Sarah B Peskoe, Christopher M Heaphy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 22, 2014
Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trialBora Gurel, M Scott Lucia, Ian M Thompson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
A Reproducible Pipeline for Processing Commercial Wearable Step-Count Data in Aging Cohorts: Application and Evaluation in the STRRIDE-PD Reunion StudyNannan Bo, Alyssa M Sudnick, Julie D Counts, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcomePaula J Hurley, Luigi Marchionni, Brian W Simons, et al.
Pageof 6